Rein Therapeutics, Inc. Investing Cash Flow
Rein Therapeutics, Inc. (RNTX) reported Investing Cash Flow of -$35.07 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-14
- Rein Therapeutics, Inc. net cash provided by (used in) investing activities for the quarter ending 2024-12-31 was $0.00.
- Rein Therapeutics, Inc. net cash provided by (used in) investing activities for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- Rein Therapeutics, Inc. net cash provided by (used in) investing activities for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- Rein Therapeutics, Inc. net cash provided by (used in) investing activities for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- Rein Therapeutics, Inc. net cash provided by (used in) investing activities for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- Rein Therapeutics, Inc. net cash provided by (used in) investing activities for fiscal 2023 was $16.20M, a 38.79% decline from fiscal 2022.
- Rein Therapeutics, Inc. net cash provided by (used in) investing activities for fiscal 2022 was $26.46M.
- Rein Therapeutics, Inc. net cash provided by (used in) investing activities for fiscal 2021 was -$35.92M, a 660.24% decline from fiscal 2020.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$35.07M 10-Q · filed 2026-08-14 | |||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-14 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-07 | $0.00 derived: sum of 2 quarters · filed 2025-04-07 | $0.00 derived: sum of 3 quarters · filed 2025-04-07 | $0.00 10-K · filed 2025-04-07 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $0.00 derived: sum of 2 quarters · filed 2024-11-14 | $0.00 10-Q · filed 2024-11-14 | -$96.00K derived: sum of 4 quarters · filed 2025-04-07 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $0.00 10-Q · filed 2024-08-14 | -$96.00K derived: sum of 3 quarters · filed 2025-04-07 | $446.00K derived: sum of 4 quarters · filed 2025-04-07 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-15 | -$96.00K derived: sum of 2 quarters · filed 2025-04-07 | $446.00K derived: sum of 3 quarters · filed 2025-04-07 | $8.95M derived: sum of 4 quarters · filed 2025-04-07 |
| 2023-12-31 | -$96.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-07 | $446.00K derived: sum of 2 quarters · filed 2025-04-07 | $8.95M derived: sum of 3 quarters · filed 2025-04-07 | $16.20M 10-K · filed 2025-04-07 |
| 2023-09-30 | $542.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $9.04M derived: sum of 2 quarters · filed 2024-11-14 | $16.29M 10-Q · filed 2024-11-14 | $21.06M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $8.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $15.75M 10-Q · filed 2024-08-14 | $20.51M derived: sum of 3 quarters · filed 2024-08-14 | $24.70M derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $7.25M 10-Q · filed 2024-05-15 | $12.01M derived: sum of 2 quarters · filed 2024-05-15 | $16.20M derived: sum of 3 quarters · filed 2024-05-15 | $22.06M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $4.76M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-15 | $8.95M derived: sum of 2 quarters · filed 2024-04-15 | $14.81M derived: sum of 3 quarters · filed 2024-04-15 | $26.46M 10-K · filed 2024-04-15 |
| 2022-09-30 | $4.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-13 | $10.05M derived: sum of 2 quarters · filed 2023-10-13 | $21.70M 10-Q · filed 2023-10-13 | $23.95M derived: sum of 4 quarters · filed 2023-10-13 |
| 2022-06-30 | $5.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $17.51M 10-Q · filed 2023-08-11 | $19.76M derived: sum of 3 quarters · filed 2023-08-11 | $23.85M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $11.65M 10-Q · filed 2023-05-08 | $13.90M derived: sum of 2 quarters · filed 2023-05-08 | $17.99M derived: sum of 3 quarters · filed 2023-05-08 | $13.19M derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | $2.25M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | $6.34M derived: sum of 2 quarters · filed 2023-03-20 | $1.54M derived: sum of 3 quarters · filed 2023-03-20 | -$35.92M 10-K · filed 2023-03-20 |
| 2021-09-30 | $4.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | -$709.00K derived: sum of 2 quarters · filed 2022-11-01 | -$38.17M 10-Q · filed 2022-11-01 | -$38.52M derived: sum of 4 quarters · filed 2022-11-01 |
| 2021-06-30 | -$4.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$42.26M 10-Q · filed 2022-08-15 | -$42.61M derived: sum of 3 quarters · filed 2022-08-15 | -$47.14M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | -$37.46M 10-Q · filed 2022-05-05 | -$37.82M derived: sum of 2 quarters · filed 2022-05-05 | -$42.34M derived: sum of 3 quarters · filed 2022-05-05 | -$42.11M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | -$357.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | -$4.89M derived: sum of 2 quarters · filed 2022-03-28 | -$4.65M derived: sum of 3 quarters · filed 2022-03-28 | $6.41M 10-K · filed 2022-03-28 |
| 2020-09-30 | -$4.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$4.29M derived: sum of 2 quarters · filed 2021-11-12 | $6.77M 10-Q · filed 2021-11-12 | $11.53M derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $239.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $11.30M 10-Q · filed 2021-08-11 | $16.06M derived: sum of 3 quarters · filed 2021-08-11 | $19.80M derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | $11.06M 10-Q · filed 2021-05-11 | $15.82M derived: sum of 2 quarters · filed 2021-05-11 | $19.56M derived: sum of 3 quarters · filed 2021-05-11 | $271.00K derived: sum of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | $4.76M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | $8.50M derived: sum of 2 quarters · filed 2021-03-24 | -$10.79M derived: sum of 3 quarters · filed 2021-03-24 | -$2.81M 10-K · filed 2021-03-24 |
| 2019-09-30 | $3.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$15.55M derived: sum of 2 quarters · filed 2020-11-12 | -$7.58M 10-Q · filed 2020-11-12 | $727.00K derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | -$19.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$11.31M 10-Q · filed 2020-08-05 | -$3.01M derived: sum of 3 quarters · filed 2020-08-05 | -$1.61M derived: sum of 4 quarters · filed 2020-08-05 |
| 2019-03-31 | $7.97M 10-Q · filed 2020-05-11 | $16.28M derived: sum of 2 quarters · filed 2020-05-11 | $17.68M derived: sum of 3 quarters · filed 2020-05-11 | $30.26M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $8.30M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $9.71M derived: sum of 2 quarters · filed 2020-03-30 | $22.29M derived: sum of 3 quarters · filed 2020-03-30 | $24.69M 10-K · filed 2020-03-30 |
| 2018-09-30 | $1.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $13.98M derived: sum of 2 quarters · filed 2019-11-07 | $16.38M 10-Q · filed 2019-11-07 | $20.90M derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $12.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $14.98M 10-Q · filed 2019-08-06 | $19.50M derived: sum of 3 quarters · filed 2019-08-06 | -$21.94M derived: sum of 4 quarters · filed 2019-08-06 |
| 2018-03-31 | $2.40M 10-Q · filed 2019-05-08 | $6.92M derived: sum of 2 quarters · filed 2019-05-08 | -$34.52M derived: sum of 3 quarters · filed 2019-05-08 | |
| 2017-12-31 | $4.52M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | -$36.92M derived: sum of 2 quarters · filed 2019-03-29 | -$38.91M 10-K · filed 2019-03-29 | |
| 2017-09-30 | -$41.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$43.43M 10-Q · filed 2018-11-07 | ||
| 2017-06-30 | -$1.99M 10-Q · filed 2018-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |